Transcranial Magnetic Stimulation Course

Transcranial Magnetic Stimulation Course

Course Description

The 3-day 20 AMA PRA Category 1 Credit(s)TM course offers intensive training on the FDA-cleared treatment for major depression, Transcranial Magnetic Stimulation (TMS).  Sponsored by the Duke University School of Medicine, it includes didactic sessions and hands-on administration of TMS.  The didactic sessions with the TMS faculty from Duke University cover all topics relevant to running a TMS clinical service and a TMS research lab, including: device principles and types; the neuroscience of TMS; motor threshold determination; treatment technique; stimulus dosing; risks, complications, and contraindications; safety screening; post TMS management and continuation treatment; clinical and non-clinical research applications; and emerging brain stimulation techniques. The course cost is $2,600.

This activity is designed for psychiatrists, psychologists, and researchers who wish to enhance their knowledge of TMS and related brain stimulation techniques. The course session is capped at 20 participants.

The 3-day course is held on Saturday from 8:30 am - 5:00 pm, Sunday from 8:30 am - 7:00 pm, and Monday from 8:30 am - 2:30 pm. Helpful Hints

Learning Objectives 

At the conclusion of this activity, participants should be able to:

  • State the rationale for the use of TMS in depression, obsessive compulsive disorder, and off-label conditions
  • Explain regulatory issues and policies concerning TMS
  • Name the two main components of transcranial magnetic stimulation devices
  • Operate the TMS device and correctly use it to determine the optimal site and motor threshold
  • Describe the findings from TMS research in imaging and motor cortex excitability studies
  • Apply the indications for use of TMS in depression
  • Identify the risks and side effects of TMS and describe how to conduct a safety screening
  • Design a protocol for seizure management during TMS administration
  • Outline steps necessary to set up a TMS service/lab

2019 Course Dates

The fellowship is currently offered on a quarterly basis.
  • January 12-14, 2019
  • April 27-29, 2019
  • July 13-15, 2019 
  • October 19-21, 2019

CME Credit:

You must attend all three days of the course in order to receive full credit for the course. You must sign-in for all three days.

Register Here

Faculty

Lawrence Appelbaum
Associate Professor in Psychiatry and Behavioral Sciences
Psychiatry & Behavioral Sciences, Brain Stimulation and Neurophysiology
School of Medicine

greg.appelbaum@duke.edu

Greg Appelbaum is an Associate Professor in the Department of Psychiatry and Behavioral Sciences in the Duke University School of Medicine. He is a member of the Brain Stimulation Division of Psychiatry, where he directs the Human Performance Optimization lab (Opti Lab) and the Brain Stimulation Service Center   As a member of the Duke Institute for Brain Sciences he teaches and advises in the Neuroscience major, is an affiliate of the Center for Cognitive Neuroscience, and has a secondary appointment in the Department of Psychology and Neuroscience.

Dr. Appelbaum's research interests primarily concern the brain mechanisms underlying visual cognition, how these capabilities differ among individuals, and how they can be improved through behavioral, neurofeedback, and neuromodulation interventions. Within the field of cognitive neuroscience, his research has addressed visual perception, sensorimotor function, executive function, decision-making, and learning/expertise. In this research, he has utilized a combination of behavioral psychophysics coupled with the neuroscience techniques of electroencephalography (EEG), transcranial magnetic stimulation (TMS), functional magnetic resonance imaging (fMRI), and functional near infrared spectroscopy (fNIRS).

 
Simon W Davis, PhD
Assistant Professor, Dept of Neurology
Duke University

simon.davis@duke.edu  

Dr. Simon Davis is an Assistant Professor in the Department of Neurology in the Duke University School of Medicine. Dr. Davis received his BA from New College of FL, an MSc in Neuropsychology from University College London, and a PhD in Psychology & Neuroscience from Duke University. His lab at Duke specializes in structural, functional, and causal approaches to the investigation of the dynamics of the normal and demented aging brain.

 
Sarah H. Lisanby, MD
NIMH (National Institute of Mental Health)
Adjunct Professor in the Department of Psychiatry and Behavioral Sciences, Duke University
 
Dr. Lisanby earned her BS in mathematics and psychology magna cum laude at Duke University and her MD at Duke University School of Medicine in Durham, North Carolina. After graduating, she completed a residency in psychiatry at Duke University Medical Center, where she served as Executive Chief Resident. Her postdoctoral fellowship in affective disorders research and geriatric psychiatry was conducted at Columbia University. After serving as Brain Stimulation Division Director at Columbia University, she became chair of psychiatry at Duke in October 2010. She became a leader in the field of TMS when her research team innovated the use of TMS to perform convulsive therapy – a procedure termed Magnetic Seizure Therapy (MST). Currently at NIMH in Bethesda, MD.

 

Bruce M. Luber, PhD

Dr. Luber received his PhD in experimental psychology from NYU, researching spatial attention using magnetoencephalopgraphy (MEG). His post-doctorate work at Columbia University/NY State Psychiatric Institute focused on the electrophysiology of memory and of ECT. He joined Dr. Holly Lisanby in the then new field of transcranial magnetic stimulation (TMS) at Columbia in 1995. With Dr. Lisanby and collaborators he researched the cortical mechanisms underlying working memory, conditioned learning, pain, deception, and self-recognition. His primary focus is on the use of TMS to explore executive function and memory, and its applications to geriatric psychiatry. He was on the faculty at Columbia University until November 2010 when he moved to Duke University. In 2015, he moved to the NIMH in Bethesda, MD.

 
Andrada Neacsiu, PhD
Assistant Professor
Duke University

Andrada.neacsiu@duke.edu

Dr. Andrada Neacsiu is a clinical psychologist with a primary interest in outpatient interventions for difficulties managing emotional experiences that interfere with well-being. As a clinician, she specialize in Dialectical Behavior Therapy (DBT) and Cognitive Behavioral Therapy (CBT) for adults who report a variety of mental health problems, including personality, mood, anxiety, eating, trauma, stress-related, adjustment, and impulse control disorders. Her approach to psychotherapy includes working collaboratively with my patients to identify their unique life and therapy goals and to implement evidence-based interventions in order to achieve their identified goals. As an educator, she trains clinicians nationally and teaches Duke graduate students, psychology and psychiatry residents in in how to effectively apply CBT and DBT in their clinical work. As a researcher, she focuses on psychotherapy optimization and neuroscience-informed treatment development for emotion dysregulation. Her research keeps her up to date with the latest evidence-based approaches to use in her clinical work, and her work with patients strongly influences the research that she does. Outside of work, she enjoys traveling, gourmet food, nature adventures, and time with friends and family.

 
Angel V. Peterchev, PhD
Associate Professor of Psychiatry and Behavioral Sciences, Biomedical Engineering, and Electrical & Computer Engineering
Department of Neurosurgery
Duke University

Angel.peterchev@duke.edu  

Dr. Peterchev received the A.B. degree in physics and engineering sciences from Harvard University in 1999 and the M.S. and Ph.D. degrees in electrical engineering with a graduate-level minor in cognitive neuroscience from the University of California at Berkeley in 2002 and 2005, respectively. He completed postdoctoral training in TMS at Columbia University in 2007, and remained on the faculty there until the end of 2010 when he moved to Duke University. Dr. Peterchev’s current research focuses on the development and modeling of technology and application paradigms for transcranial brain stimulation, including TMS, electroconvulsive therapy (ECT), magnetic seizure therapy (MST), and the integration of TMS with functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). The ultimate clinical goal of his work is to make transcranial stimulation techniques robustly effective and safe.

 
Sandeep Vaishnavi, MD, PhD
Clinical Associate, Division of Brain Stimulation and Neurophysiology, Department of Psychiatry
Consulting Associate, Department of Community and Family Medicine
Neuropsychiatrist, The Preston Robert Tisch Brain Tumor Center
Duke University
Director, The Neuropsychiatric Clinic at Carolina Partners
Director, Carolina Partners Clinical Trials Institute
Director, Carolina Partners TMS Program

Sandeep.vaishnavi@duke.edu

Dr. Vaishnavi received his MD and PhD from the University of Alabama at Birmingham.  He did his residency in Psychiatry at Duke University, as well as a Clinical Psychopharmacology residency at Duke University and GlaxoSmithKline.  He did his fellowship in Behavioral Neurology & Neuropsychiatry at Johns Hopkins.  He is board-certified in Behavioral Neurology & Neuropsychiatry, as well as General Psychiatry.  He is the coauthor of The Traumatized Brain (Johns Hopkins University Press, 2015).  He is interested in the interface of neurology and psychiatry (mood, behavioral, and cognitive symptoms in neurological disorders, including traumatic brain injury, brain tumor, and stroke).  He is also interested in studying and using biomarkers, objective assessments, and neuroscience-based treatments for psychiatric disorders.  

 
Richard Weiner, MD, PhD
Professor and Executive Vice-Chair for Psychiatry and Behavioral Sciences, Duke University School of Medicine

weine002@duke.edu

A professor in the Department of Psychiatry and Behavioral Sciences, Dr. Weiner is recognized as an accomplished physician-researcher and educator with nearly four decades of service at Duke. His research, continuously funded for many years by the NIMH and VA, was instrumental in the development of newer safe and effective types of electroconvulsive therapy (ECT) in the treatment of individuals with severe depressive disorders. Dr. Weiner directs the Duke ECT Program and has authored over 150 publications in that area of research.  He has served as chief of the Mental Health Service Line at the Durham VA Medical Center for the past 21 years before serving as interim chair of the Department of Psychiatry and Behavioral Sciences from Oct. 1, 2015 until June 30, 2017. Dr. Weiner received a bachelor’s degree in Electrical Engineering at M.I.T. and a master’s degree in Systems Engineering and Operations Research at the University of Pennsylvania. He received his MD and his PhD in Physiology in 1974 through the Duke Medical Scientist Training Program and completed his residency in Psychiatry at the University of North Carolina before joining the Duke faculty in 1977.

Planning Committee/Faculty Disclosure

The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity:

  • Bruce Luber, PhD
  • Simon Davis, PhD
  • Andrada Neacsiu, PhD

The following speaker/planning committee member have indicated that s/he has relationship(s) with industry to disclose:

  • Angel V. Peterchev, PhD, is inventor on patents and patent applications and has received research and travel support as well as patent royalties from Rogue Research, research and travel support, consulting fees, as well as equipment loan from Tal Medical, patent application support from Magstim, as well as equipment loans from MagVenture, all related to technology for TMS.
  • Sarah H. Lisanby, MD, fulfills the role of Principal Investigator for Brainsway, Magstim, Magventure, Neosync, Nexstim.
  • Sandeep Vaishnavi, MD, PhD, is currently an investigator in an industry-sponsored trial of TMS for PTSD with Brainsway.

Disclaimer

The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Credit Designation

Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credit(s)TMPhysicians should claim only credit commensurate with the extent of their participation in the activity. 

Accreditation Statement

Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Contact Information

DukeTMS@dm.duke.edu
Ph: 919-613-6958
Fax: 919-681-0602